lenvatinib pembrolizumab in rcc, the clear trial with karine tawagi
Published 3 years ago • 1.7K plays • Length 32:46Download video MP4
Download video MP3
Similar videos
-
0:59
combining lenvatinib & pembrolizumab for non-clear cell rcc: keynote-b61 study rationale
-
3:15
phase ii study of petosemtamab and pembrolizumab for recurrent/metastatic hnscc
-
0:49
clear: lenvatinib and pembrolizumab in advanced renal cell carcinoma
-
33:06
are rcts needed for new cancer drugs? | two oncologists discuss
-
1:28
keynote-b61: first-line lenvatinib pembrolizumab in non-clear cell rcc
-
28:42
lecture 6a: in vitro cell types
-
4:05
refusing to read, listen or link to something while disagreeing
-
5:09
recent advances in treating advanced kidney cancer
-
3:28
dr rini on a biomarker analysis for pembrolizumab/axitinib in advanced rcc
-
1:44
assessing lenvatinib with pembrolizumab in advanced renal cell carcinoma
-
1:01:58
multiple myeloma round table - initial therapy, high risk, maintenance
-
2:21
lba41 - leap-005: phase ii study of lenvatinib plus pembrolizumab
-
6:42
the role of lenvatinib in advanced rcc
-
2:08
clear: lenvatinib and pembrolizumab efficacy in arcc across baseline tumor sizes
-
1:10:27
3.23 capturing your audience with dr. zubin "zdoggmd" damania & javelin 100 with dr. karine tawagi
-
2:06
lenvatinib plus pembro for arcc - update on the clear study
-
24:00
mark lythgoe reporting of race in trials sent to fda
-
5:14
lenvatinib plus pembrolizumab after progression on immune checkpoint inhibitors for metastatic rcc
-
2:13
dr. hutson on lenvatinib/everolimus combo in rcc
-
3:29
lenvatinib and pembrolizumab in microsatellite stable crc
-
1:04
dr. rini discusses pembrolizumab plus axitinib in mrcc
-
1:22
discussing the phase ii study of lenvatinib/pembrolizumab in metastatic ccrcc